Working Document, September 2017
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Key Populations Brief
Accessed November 2017
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
3rd Edition – July 2017
www.msfaccess.org
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...ce of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more